Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine whether the effect of ondansetron on the analgesic effect of acetaminophen. Because 5HT3 blockers prevent the analgesic effects of acetaminophen and also reduce opioid consumption

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effects of Morphine on Desflurane Consumption and Recovery Time

NCT02362022

Abdominal Hysterectomy (& Wertheim)

COMPLETED PHASE4

Postoperative Analgesia in Patients With Microvascular Decompression

NCT03152955

Trigeminal Neuralgia

UNKNOWN PHASE4

Prevention of Propofol Injection Pain

NCT02203175

Pain

COMPLETED PHASE2/PHASE3

Perioperative Epidural Anesthesia and Analgesia on Gut Microbiota

NCT04079673

Living Donor Hepatectomy

UNKNOWN NA

Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Nontraumatic Musculoskeletal Pain

NCT03122314

Musculoskeletal Pain

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators enrolled 80 American Society of Anesthesiologists Physical Status I-II women 18-80 years old scheduled for hysterectomy under general anesthesia over the course of a year. The study will be restricted hysterectomies with horizontal abdominal skin incision who will be able to operate a patient-controlled analgesia (PCA) device.

Participating women will be premedicated with 1-2 mg intravenous (IV) midazolam per preference of the attending anesthesiologist.

Anesthesia will be induced with propofol (2 mg/kg IV); intubation will be facilitated by rocuronium (0.6 mg/kg IV); and anesthesia will be maintained by sevoflurane in combination with nitrous oxide 50% in oxygen. Fentanyl, 2 µg/kg intravenous will be given 3-5 min before the surgical incision.

After endotracheal intubation, all patients' lungs will be mechanically ventilated to maintain the end-expiratory carbon dioxide values between 34 and 36 mmHg.

A Pfannenstiel approach will be used in each woman, and the same surgeon will be conducted all operations.

Randomization will be web-based and out of the control of any investigator. The web system will be accessed by the anesthesia resident at the induction. Drugs will be covered by opaque plastic to keep the surgical team and anesthesiologists blinded to treatment.

Both groups patients will be received 1 g acetaminophen in 100 ml saline given every 6 hours starting with the skin closure for 24 hours, an amount generally regarded as safe.

1. Group I patients will be received '8 mg ondansetron hydrochloride'
2. Group II patients will be received '2 ml saline' Both of them will be applied in a 100 ml saline bag at the same time with the skin closure.

After return of spontaneous ventilation and tracheal extubation, patients will be transferred to the post anesthesia care unit (PACU).

Patients were connected to a patient-controlled analgesia (PCA) device and postoperative analgesia will be provided using 20-mg intravenous bolus injections of tramadol at a lockout interval of 15 min and with a maximum 4-h limit of 150 mg. The PCA device will be discontinued when the patient made no demands for the opioid analgesic in the preceding 4-h interval or at a maximum of 24 hours after surgery.

* heart rate
* systolic arterial blood pressures
* diastolic arterial blood pressures
* mean arterial blood pressures
* oxygen saturation
* respiratory rate
* visual analogue scales while sitting and laying
* tramadol consumption
* additive analgesics
* complications
* postoperative nausea and vomiting scores
* antiemetic use will be assessed at PACU, 1th. hour, 4th hour, 8th hour, 12th hour, 16th hour, 20th hour and 24th hour.
* Pain satisfaction scale
* ambulation time
* first flatus time
* oral intake time
* Hospital anxiety and depression scale

When pain scores were VAS ≥5, then as a rescue analgesics 75 mg diclofenac Na intramuscularly will be given. If systolic arterial pressure (SAP) will be \<90 mmHg or mean arterial pressure will be \<50 mmHg, 5 mg intravenous ephedrine HCl will be given. If the heart rate will be \<50 beats/minute, 0.5 mg atropine sulfate intravenous will be given. When patients sustained nausea or vomiting lasting longer than 5 minutes, metoclopramide (10 mg intravenously) will be given.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ondansetron

ondansetron iv, 8 mg, skin closure time

Group Type ACTIVE_COMPARATOR

ondansetron

Intervention Type DRUG

8 mg intravenous in the skin closure

isotonic

isotonic 2ml, once, skin closure time

Group Type PLACEBO_COMPARATOR

isotonic

Intervention Type DRUG

8 mg intravenous in the skin closure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ondansetron

8 mg intravenous in the skin closure

Intervention Type DRUG

isotonic

8 mg intravenous in the skin closure

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Zofran

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients 18-80 years old scheduled for hysterectomy
* Horizontal or vertical abdominal skin incision
* Ability to operate a patient-controlled analgesia (PCA) device
* Written informed consent.

Exclusion Criteria

* Emergency or urgent procedures
* Women with pre-existing chronic pain at any site requiring opioid analgesia
* Who had a history of significant Axis I psychiatric disease (major depressive disorder, bipolar disorder, schizophrenia, etc.)
* Significant hepatic (alanine aminotransferase or aspartate aminotransferase \>2 times normal) or renal (serum creatinine \>2 mg/dl) impairment
* Allergy to ondansetron or acetaminophen
* Were pregnant

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No